SOURCE: Marathon Patent Group

Marathon Patent Group

July 09, 2015 09:00 ET

Marathon Patent Group, Inc.'s Subsidiary, E2E Processing, Inc. Receives Markman Ruling

LOS ANGELES, CA--(Marketwired - Jul 9, 2015) - Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"), a patent licensing company, announced today that on July 2, 2015, the United States District Court for the Eastern District of Texas issued the claim construction order in the litigation involving its wholly-owned subsidiary E2E Processing, Inc. ("E2E").

Doug Croxall, Chief Executive Officer of Marathon, stated, "The Markman order is very encouraging. While we believe it has the potential to motivate possible resolution in the form of a reasonable licensing agreement, absent such we will confidently continue to work towards the November 9th trial date."

E2E previously entered into settlement and license agreements with Nordstrom, Inc., Crocs, Inc. and LLC.

E2E had previously asserted infringement related to U.S. Patent 6,981,222, entitled "End-to-end transaction processing and statusing system and method." The E2E portfolio consists of four (4) issued patents that disclose systems for achieving process improvements in the production and Enterprise Resource Planning (ERP) space.

Liner LLP represents E2E in these enforcement cases. The complete Markman Order may be found at the company's website.

About Marathon Patent Group

Marathon is a patent acquisition and monetization company. The Company acquires patents from a wide-range of patent holders from individual inventors to Fortune 500 companies. Marathon's strategy of acquiring patents that cover a wide-range of subject matter allows the Company to achieve diversity within its patent asset portfolio. Marathon generates revenue with its diversified portfolio through actively managed concurrent patent rights enforcement campaigns. This approach is expected to result in a long-term, diversified revenue stream. To learn more about Marathon Patent Group, visit

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact Information